FDA recall record

Aspire Food Group USA EXO Cricket Protein Bar Peanut Butter and Jelly recall — FDA F-1112-2018

Products contain undeclared sulfites

Class Iclassification
F-1112-2018official record ID
Apr 25, 2018report date

Recall record at a glance

Official recordF-1112-2018
CategoryFood Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmAspire Food Group USA Inc.
Report dateApr 25, 2018
Recall initiation dateMar 16, 2018
Quantity27,128 units
LocationAustin, TX, United States

Official product description

EXO Cricket Protein Bar Peanut Butter and Jelly; Net Wt 2.1 Oz. packaged in a film wrapper, 12 units per case; UPC: 861703000014

Why the product was recalled

Products contain undeclared sulfites

Distribution information

United States and Germany

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.